drugset / Trial / NCT00003946
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
Treatment
Summary
RATIONALE: Hormone therapy may be an effective treatment for endometrial cancer. PURPOSE: Phase II trial to study the effectiveness of danazol in treating patients with advanced or recurrent endometrial cancer.
Timeline
- Start
- 1999-08
- Primary completion
- 2003-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Danazol | Other / unclassified | 100 mg | Oral |